Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Carlos M Ferrario & Ronald D Smith. (2010) Role of olmesartan in combination therapy in blood pressure control and vascular function. Vascular Health and Risk Management 6, pages 701-709.
Read now
Read now
Eduardo Pimenta & Suzanne Oparil. (2010) Impact of olmesartan on blood pressure, endothelial function, and cardiovascular outcomes. Integrated Blood Pressure Control 3, pages 113-123.
Read now
Read now
Articles from other publishers (25)
Hiroaki Ichikawa, Ikuyo Narita, Masato Narita, Tomohiro Tanno, Yoshikazu Yokono, Yoshihiro Kimura, Makoto Tanaka, Tomohiro Osanai, Ken Okumura & Hirofumi Tomita. (2018) Blood Pressure-Independent Effect of Olmesartan on Albuminuria in Mice Overexpressing Renin. International Heart Journal 59:6, pages 1445-1453.
Crossref
Crossref
Anna E. StanhewiczSandeep JanduLakshmi SanthanamLacy M. Alexander. (2017) Increased Angiotensin II Sensitivity Contributes to Microvascular Dysfunction in Women Who Have Had Preeclampsia. Hypertension 70:2, pages 382-389.
Crossref
Crossref
Ying Zhou, Feng Tian, Jing Wang, Jun-Jie Yang, Tao Zhang, Jing Jing & Yun-Dai Chen. (2016) Efficacy study of olmesartan medoxomil on coronary atherosclerosis progression and epicardial adipose tissue volume reduction in patients with coronary atherosclerosis detected by coronary computed tomography angiography: study protocol for a randomized controlled trial. Trials 17:1.
Crossref
Crossref
Ronnie Ramadan, Saurabh S. Dhawan, José Nilo G. Binongo, Ayman Alkhoder, Dean P. Jones, John N. Oshinski & Arshed A. Quyyumi. (2016) Effect of Angiotensin II Type I Receptor Blockade with Valsartan on Carotid Artery Atherosclerosis: A Double Blind Randomized Clinical Trial Comparing Valsartan and Placebo (EFFERVESCENT). American Heart Journal 174, pages 68-79.
Crossref
Crossref
Yasuhiro Aoki, Keishi Ishikawa, Keiichiro Miura, Kazumasa Sugimoto, Takashi Nakayama, Yoshihide Fujimoto & Yoshio Kobayashi. (2016) Protective effect of angiotensin II receptor blocker and calcium channel blocker on endothelial vasomotor function after everolimus-eluting stent implantation. Journal of Cardiology 67:3, pages 236-240.
Crossref
Crossref
Yohko Nagai, Kazushige Nakanishi, Tatsuo Akimoto & Nobuaki Yamanaka. (2013) Proliferative changes of renal arteriolar walls induced by administration of angiotensin II receptor blocker are frequent in juvenile rats. Journal of the Renin-Angiotensin-Aldosterone System 15:4, pages 440-449.
Crossref
Crossref
Kadri Murat Gurses, Lale Tokgozoglu, Muhammed Ulvi Yalcin, Duygu Kocyigit, Muhammet Dural, Hande Canpinar, Hikmet Yorgun, Mehmet Levent Sahiner, Ergun Baris Kaya, Safak Akin, Alper Gurlek, Dicle Guc & Kudret Aytemir. (2014) Markers of subclinical atherosclerosis in premenopausal women with vitamin D deficiency and effect of vitamin D replacement. Atherosclerosis 237:2, pages 784-789.
Crossref
Crossref
Meg Mangin, Rebecca Sinha & Kelly Fincher. (2014) Inflammation and vitamin D: the infection connection. Inflammation Research 63:10, pages 803-819.
Crossref
Crossref
BENHONG HE, JIANJUN HAO, WEIWEI SHENG, YUANCAI XIANG, JIEMEIA ZHANG, HAO ZHU, JINGCHENG TIAN, XU ZHU, YUNXIA FENG & HAO XIA. (2014) Fistular onion stalk extract exhibits anti-atherosclerotic effects in rats. Experimental and Therapeutic Medicine 8:3, pages 785-792.
Crossref
Crossref
I. B. Matrosova, E. A. Melnikova & V. E. Oleynikov. (2014) EFFECTS OF OLMESARTAN ON LOCAL AND REGIONAL RIGIDITY OF ARTERIES IN ISCHEMIC HEART DISEASE. Cardiovascular Therapy and Prevention 13:3, pages 41-46.
Crossref
Crossref
Stefan Peters. (2013) Inhibition of Atherosclerosis by Angiotensin II Type 1 Receptor Antagonists. American Journal of Cardiovascular Drugs 13:4, pages 221-224.
Crossref
Crossref
Tao Hu, Hai-Chang Wang, Ru-Tao Wang, An-Lin Lv, Rong-Hua Luan, Cheng-Xiang Li, He-Xiang Cheng, Cheng-Hai Xia & Ling Tao. (2013) Effect of Chronic Pretreatment of Angiotensin-Converting Receptor Blocker on No-Reflow Phenomenon in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention. Cardiovascular Therapeutics 31:3, pages e7-e11.
Crossref
Crossref
Jasmina Varagic, Sarfaraz Ahmad, Jessica L. VonCannon, Norihito Moniwa, K. Bridget Brosnihan, Jan Wysocki, Daniel Batlle & Carlos M. Ferrario. (2013) Predominance of AT1 Blockade Over Mas–Mediated Angiotensin-(1–7) Mechanisms in the Regulation of Blood Pressure and Renin–Angiotensin System in mRen2.Lewis Rats. American Journal of Hypertension 26:5, pages 583-590.
Crossref
Crossref
Vanessa Estato, Nathalie Obadia, Juliana Carvalho-Tavares, Felipe Santos Freitas, Patrícia Reis, Hugo Castro-Faria Neto, Marcos Adriano Lessa & Eduardo Tibiriçá. (2013) Blockade of the renin–angiotensin system improves cerebral microcirculatory perfusion in diabetic hypertensive rats. Microvascular Research 87, pages 41-49.
Crossref
Crossref
Wing Tak Wong, Xiao Yu Tian & Yu Huang. (2013) Endothelial Dysfunction in Diabetes and Hypertension. Journal of Cardiovascular Pharmacology 61:3, pages 204-214.
Crossref
Crossref
Hisao Mori, Hareaki Yamamoto, Hiroshi Ukai, Shouhei Yuasa, Kazumi Nakajima, Takehiko Mikawa, Masamichi Niizuma, Kouichi Hirao & Satoshi Umemura. (2012) Comparison of effects of angiotensin II receptor blocker on morning home blood pressure and cardiorenal protection between morning administration and evening administration in hypertensive patients: the COMPATIBLE study. Hypertension Research 36:3, pages 202-207.
Crossref
Crossref
Dangheng Wei, Yongpeng Chen, Chaojun Tang, Hua Huang, Lushan Liu, Zuo Wang, Ruming Li & Guixue Wang. (2012) LDL Decreases the Membrane Compliance and Cell Adhesion of Endothelial Cells Under Fluid Shear Stress. Annals of Biomedical Engineering 41:3, pages 611-618.
Crossref
Crossref
Maria M. Patarroyo Aponte & Gary S. Francis. (2012) Effect of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Antagonists in Atherosclerosis Prevention. Current Cardiology Reports 14:4, pages 433-442.
Crossref
Crossref
Kazushige NakanishiYohko Nagai, Honglan Piao, Tatsuo Akimoto, Hirohito Kato, Nadezhda Yanakieva-Georgieva, Yukio Ishikawa, Kastunori Yoshihara, Kinji Ito, Nobuaki Yamanaka & Takashi Oite. (2011) Changes in renal vessels following the long-term administration of an angiotensin II receptor blocker in Zucker fatty rats. Journal of the Renin-Angiotensin-Aldosterone System 12:2, pages 65-74.
Crossref
Crossref
Emma D. Deeks. (2011) Olmesartan Medoxomil/Amlodipine/Hydrochlorothiazide. Drugs 71:2, pages 209-220.
Crossref
Crossref
Serkan Bulur, Hakan Ozhan, Ismail Erden, Recai Alemdar, Mesut Aydin, Onur Caglar, Cengiz Basar & Serkan Ordu. (2011) Efficacy of olmesartan therapy on fibrinolytic capacity in patients with hypertension. Blood Coagulation & Fibrinolysis 22:1, pages 29-33.
Crossref
Crossref
L. Tomasoni, S. Sitia, C. Borghi, A.F.G. Cicero, C. Ceconi, F. Cecaro, A. Morganti, V. De Gennaro Colonna, M. Guazzi, L. Morricone, A.E. Malavazos, P. Marino, C. Cavallino, Y. Shoenfeld & M. Turiel. (2010) Effects of treatment strategy on endothelial function. Autoimmunity Reviews 9:12, pages 840-844.
Crossref
Crossref
Haroon Kamran, Louis Salciccioli, Bhuvaneshwari Venkatesan, Vinod Namana, Paraag Kumar, Sergei Pushilin, Muhammed Umer & Jason Lazar. (2010) Determinants of a Blunted Carotid-to-Radial Pulse Wave Velocity Decline in Response to Hyperemia. Angiology 61:6, pages 591-594.
Crossref
Crossref
Ali A. Rizvi. (2010) Hypertension, Obesity, and Inflammation: The Complex Designs of a Deadly Trio. Metabolic Syndrome and Related Disorders 8:4, pages 287-294.
Crossref
Crossref
Maki Hosoya, Junko Ohashi, Ayuko Sawada, Aya Takaki & Hiroaki Shimokawa. (2010) Combination Therapy With Olmesartan and Azelnidipine Improves EDHF-Mediated Responses in Diabetic Apolipoprotein E-Deficient Mice. Circulation Journal 74:4, pages 798-806.
Crossref
Crossref